CC

Casdin Capital Portfolio holdings

AUM $1.2B
1-Year Est. Return 36.59%
This Quarter Est. Return
1 Year Est. Return
+36.59%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$942M
AUM Growth
-$132M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
39
New
Increased
Reduced
Closed

Top Buys

1
+$35.7M
2
+$28.9M
3
+$21.4M
4
GILD icon
Gilead Sciences
GILD
+$13.1M
5
CRSP icon
CRISPR Therapeutics
CRSP
+$11.3M

Top Sells

1
+$51.5M
2
+$8.19M
3
+$7.31M
4
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
+$4.73M
5
NVTA
Invitae Corporation
NVTA
+$2.19M

Sector Composition

1 Healthcare 92.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$90.6M 9.62%
1,550,000
+610,000
2
$65.5M 6.96%
670,000
3
$63.7M 6.76%
585,000
+70,000
4
$56.6M 6.01%
2,550,000
5
$56.6M 6.01%
5,073,780
6
$50.8M 5.39%
85,306
+10,422
7
$47.5M 5.05%
3,478,388
-160,000
8
$46.6M 4.95%
995,000
-10,000
9
$38M 4.03%
1,070,000
+245,000
10
$30.8M 3.27%
980,000
-232,734
11
$30.6M 3.25%
1,000,000
+700,000
12
$28.9M 3.07%
+1,319,536
13
$28.3M 3%
1,294,335
+94,335
14
$26M 2.76%
1,076,039
15
$25.5M 2.7%
1,455,000
+205,000
16
$23.5M 2.49%
2,468,571
17
$22M 2.34%
793,125
+330,000
18
$18.7M 1.98%
185,690
-7,943
19
$15.3M 1.63%
300,000
20
$14.4M 1.53%
1,209,285
-30,000
21
$13.9M 1.47%
3,365,000
22
$13.2M 1.4%
2,270,000
+110,000
23
$13.1M 1.39%
+175,000
24
$11.3M 1.2%
+266,430
25
$11.1M 1.17%
385,000
+155,000
1
2